FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387541294> ?p ?o ?g. }

• W4387541294 abstract "We investigated the therapeutic efficacy of umbilical cord blood (UCB)-derived M1 macrophage exosomes loaded with cisplatin (CIS) in ovarian cancer and platinum resistance. M1 macrophages were purified by using CD14 magnetic beads and characterized by flow cytometry. Our analyses included morphology, particle size, particle concentration, potential, drug loading capacity, counts of entry into cells, antitumor effect in vivo, and the ability to reverse drug resistance. A2780, SKOV3, and A2780/DDP, SKOV3/DDP ovarian cancer cells (CIS-sensitive and CIS-resistant cell lines, respectively) were treated with CIS or CIS-loaded M1 macrophage exosomes (M1exoCISs). The encapsulation efficiency of CIS loading into M1 macrophage exosomes was approximately 30%. In vitro, M1exoCIS treatment reduced the CIS IC50 values of both A2780, SKOV3, and A2780/DDP, SKOV3/DDP cells. We evaluated the effect of M1exoCIS on tumor growth using a mouse ovarian cancer subcutaneous transplantation tumor model inoculated with A2780/DDP cells. M1exoCIS was observed in the liver, spleen, and tumor sites 24 h posttreatment; the fluorescence intensity of M1exoCIS is higher than that of CIS. After 7 days, M1exoCIS significantly inhibited the growth of subcutaneously transplanted tumors compared with CIS alone and had a longer survival time. Moreover, the toxicity test shows that M1exoCIS has less hepatorenal toxicity than CIS. To investigate the mechanism of M1exoCIS targeting, homing, and reversing drug resistance, we performed RT-PCR, Western blotting, and Proteome Profiler Human Receptor Array analyses. We found that A2780 and A2780/DDP cells expressed the integrin β1/CD29 receptor, while M1 exosomes expressed integrin β1/CD29. In addition, M1exos carries long noncoding RNA H19, implicated in PTEN protein upregulation and miR-130a and Pgp gene downregulation, leading to the reversal of CIS drug resistance. Therefore, UCB-derived M1exoCIS target tumor sites of ovarian cancer in vivo and can be used to increase the CIS sensitivity and cytotoxicity." @default.
• W4387541294 created "2023-10-12" @default.
• W4387541294 creator A5001969147 @default.
• W4387541294 creator A5006948242 @default.
• W4387541294 creator A5009247766 @default.
• W4387541294 creator A5041318664 @default.
• W4387541294 creator A5045545412 @default.
• W4387541294 creator A5051439492 @default.
• W4387541294 creator A5057287134 @default.
• W4387541294 date "2023-10-11" @default.
• W4387541294 modified "2023-10-16" @default.
• W4387541294 title "Umbilical Cord Blood-Derived M1 Macrophage Exosomes Loaded with Cisplatin Target Ovarian Cancer <i>In Vivo</i> and Reverse Cisplatin Resistance" @default.
• W4387541294 cites W1526822145 @default.
• W4387541294 cites W1644311940 @default.
• W4387541294 cites W1877686344 @default.
• W4387541294 cites W1971620413 @default.
• W4387541294 cites W1986321004 @default.
• W4387541294 cites W2003343932 @default.
• W4387541294 cites W2003878474 @default.
• W4387541294 cites W2041095116 @default.
• W4387541294 cites W2060571263 @default.
• W4387541294 cites W2066843867 @default.
• W4387541294 cites W2071811082 @default.
• W4387541294 cites W2073311119 @default.
• W4387541294 cites W2090968329 @default.
• W4387541294 cites W2091250479 @default.
• W4387541294 cites W2113777630 @default.
• W4387541294 cites W2114725749 @default.
• W4387541294 cites W2114915163 @default.
• W4387541294 cites W2135830946 @default.
• W4387541294 cites W2145635105 @default.
• W4387541294 cites W2152951712 @default.
• W4387541294 cites W2159801541 @default.
• W4387541294 cites W2164277862 @default.
• W4387541294 cites W2168543083 @default.
• W4387541294 cites W2176918495 @default.
• W4387541294 cites W2281134225 @default.
• W4387541294 cites W2520300236 @default.
• W4387541294 cites W2529607059 @default.
• W4387541294 cites W2734802465 @default.
• W4387541294 cites W2789444905 @default.
• W4387541294 cites W2801887850 @default.
• W4387541294 cites W2897926526 @default.
• W4387541294 cites W2936912607 @default.
• W4387541294 cites W2937766145 @default.
• W4387541294 cites W2944719766 @default.
• W4387541294 cites W2948801792 @default.
• W4387541294 cites W3030279988 @default.
• W4387541294 cites W3210711444 @default.
• W4387541294 doi "https://doi.org/10.1021/acs.molpharmaceut.3c00132" @default.
• W4387541294 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37819754" @default.
• W4387541294 hasPublicationYear "2023" @default.
• W4387541294 type Work @default.
• W4387541294 citedByCount "0" @default.
• W4387541294 crossrefType "journal-article" @default.
• W4387541294 hasAuthorship W4387541294A5001969147 @default.
• W4387541294 hasAuthorship W4387541294A5006948242 @default.
• W4387541294 hasAuthorship W4387541294A5009247766 @default.
• W4387541294 hasAuthorship W4387541294A5041318664 @default.
• W4387541294 hasAuthorship W4387541294A5045545412 @default.
• W4387541294 hasAuthorship W4387541294A5051439492 @default.
• W4387541294 hasAuthorship W4387541294A5057287134 @default.
• W4387541294 hasConcept C104317684 @default.
• W4387541294 hasConcept C121608353 @default.
• W4387541294 hasConcept C126322002 @default.
• W4387541294 hasConcept C145059251 @default.
• W4387541294 hasConcept C150903083 @default.
• W4387541294 hasConcept C153911025 @default.
• W4387541294 hasConcept C185592680 @default.
• W4387541294 hasConcept C20518536 @default.
• W4387541294 hasConcept C207001950 @default.
• W4387541294 hasConcept C2776694085 @default.
• W4387541294 hasConcept C2778239845 @default.
• W4387541294 hasConcept C2780427987 @default.
• W4387541294 hasConcept C502942594 @default.
• W4387541294 hasConcept C55493867 @default.
• W4387541294 hasConcept C71924100 @default.
• W4387541294 hasConcept C86803240 @default.
• W4387541294 hasConcept C98274493 @default.
• W4387541294 hasConceptScore W4387541294C104317684 @default.
• W4387541294 hasConceptScore W4387541294C121608353 @default.
• W4387541294 hasConceptScore W4387541294C126322002 @default.
• W4387541294 hasConceptScore W4387541294C145059251 @default.
• W4387541294 hasConceptScore W4387541294C150903083 @default.
• W4387541294 hasConceptScore W4387541294C153911025 @default.
• W4387541294 hasConceptScore W4387541294C185592680 @default.
• W4387541294 hasConceptScore W4387541294C20518536 @default.
• W4387541294 hasConceptScore W4387541294C207001950 @default.
• W4387541294 hasConceptScore W4387541294C2776694085 @default.
• W4387541294 hasConceptScore W4387541294C2778239845 @default.
• W4387541294 hasConceptScore W4387541294C2780427987 @default.
• W4387541294 hasConceptScore W4387541294C502942594 @default.
• W4387541294 hasConceptScore W4387541294C55493867 @default.
• W4387541294 hasConceptScore W4387541294C71924100 @default.
• W4387541294 hasConceptScore W4387541294C86803240 @default.
• W4387541294 hasConceptScore W4387541294C98274493 @default.
• W4387541294 hasFunder F4320321001 @default.
• W4387541294 hasLocation W43875412941 @default.
• W4387541294 hasLocation W43875412942 @default.
• W4387541294 hasOpenAccess W4387541294 @default.

• next